A risk index for prostate cancer

International Journal of Urology

Volumn 11, Issue 5, 2004, Pages 310-315

  Matchariyakul, Chaiyasit ^a   Kochakarn, Wachira ^a   Chaimuangraj, Suchart ^a   Leenanupunth, Chareon ^a   Lertsithichai, Panuwat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Prostate biopsy; Prostate cancer; Risk index

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; FINGER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PATIENT SELECTION; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; RECTUM; RISK ASSESSMENT; RISK INDEX; THAILAND; TRANSRECTAL ULTRASONOGRAPHY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 2942590560     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00799.x     Document Type: Article

References (18)

1. Littrup PJ. Future benefits and cost-effectiveness of prostate carcinoma screening. American Cancer Society. Cancer 1997; 80: 1864-70.
2. Rietbergen JB, Kruger AE, Kranse R, Schroder FH. Complications of transrectal ultrasound-guided systemic sexant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997; 49: 875-80.
3. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edn. Chapman & Hall, London, 1989.
4. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall, London, 1993, p. 141-52.
5. Fisher B, Van Belle G. Biostatistics. Wiley Interscience, New York, 1994, pp. 539.
6. Roberts RO, Bergstralh EJ, Besse JA, Lieber MM, Jacobsen SJ. Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980-97. Urology 2002; 59: 79-84.
7. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7.
8. Etzioni R, Shen Y, Petteway JC, Brawer MK. Age-specific PSA. A reassessment. Prostate 1996; 7: 70-77.
9. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: results of multicenter clinical trial of 6630 men. J. Urol. 1994; 151:1283-90.
10. Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M. Prostatic specific antigen density of the transition zone for early detection of prostate cancer. J. Urol. 1998; 160: 411-8.
11. Clements R. The role of transrectal ultrasound in diagnosing prostate cancer. Curr. Urol. Report 2002; 3: 194-200.
12. Benson MC, Whang IS, Pantuck A et al. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 1992; 147: 815-21.
13. Potter SR, Carter HB. The role of prostate specific antigen velocity in prostate cancer early detection. Curr. Urol. Report 2000; 1: 15-9.
14. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J. Clin. Oncol. 2002; 20: 921-9.
15. Stephan C, Cammann H, Semjonow A et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin. Chem. 2002; 48: 1279-87.
16. Duh MS, Walker AM, Pagano M, Kronlund K. Prediction and cross-validation of neural networks versus logistic regression: using hepatic disorders as an example. Am. J. Epidemiol. 1998; 147: 407-13.
17. Duh MS, Walker AM, Ayanian JZ. Epidemiologic interpretation of artificial neural networks. Am. J. Epidemiol. 1998; 147: 1112-22.
18. Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JDF. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med. Decis. Making 2001; 21: 45-56.